Cholesterol research sparks Alltracel rise

ALLTRACEL shares surged 14% yesterday after the pharmaceutical company announced a major new product breakthrough.

The Sallynoggin-based company said trials of its m-doc technology, which until now had been used as an anti-bleeding agent in first aid products, showed it also worked to clear blockages in arteries and helped to prevent heart disease.

Previous research by the company had signalled m-doc had additional qualities that lowered cholesterol in the bloodstream.